Department of Health ministers agreed to refer the following topics to the National Institute for Health and Clinical Excellence** **(NICE) in October, to begin the process of developing guidance for each topic.
Technology appraisals
The following technology appraisals have been referred to NICE.
- To appraise the clinical and cost effectiveness of vintafolide within its licensed indication in combination with pegylated liposomal doxorubicin hydrochloride for the treatment of folate-receptor-positive, platinum-resistant ovarian cancer.
- To appraise the clinical and cost effectiveness of rituximab in combination with corticosteroids within its licensed indication for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis.
- To appraise the clinical and cost effectiveness of ranibizumab within its licensed indication for the treatment of choroidal neovascularisation associated with pathological myopia.
- To appraise the clinical and cost effectiveness of everolimus within its licensed indication for the prevention of organ rejection in allogeneic liver transplantation.
- To appraise the clinical and cost effectiveness of masitinib within its licensed indication for the treatment of locally advanced or metastatic pancreatic cancer.
- To appraise the clinical and cost effectiveness of ocriplasmin within its licensed indication for the treatment of vitreomacular traction including stage I and II macular holes with a diameter ?400µm.
Read about NICE technology appraisals on the NICE website.
About NICE referrals
NICE is an independent organisation responsible for providing national guidance on promoting good health and preventing and treating ill health.
Department of Health ministers refer topics to NICE and NICE schedules these topics into its work programme, to begin the process of developing guidance for each topic.
Depending on the type of guidance and its complexity, this can take between 6 months and 2 years.
NICE guidance includes technology appraisals, clinical guidelines, public health guidelines and quality standards.
Find out more about NICE guidance on the NICE website.